Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Laboratorios Richmond S.A.C.I.F.

Market Cap 13TCr 8.82Cr 7.6Cr 7Cr 6.57Cr 12Cr 833.5Cr 12Cr 83Cr 32Cr 408.17Cr 33Cr 32Cr 1.41TCr P/E 2024
6.08x
P/E 2025 51.6x
Enterprise Value 36TCr 25Cr 21Cr 20Cr 19Cr 35Cr 2.36TCr 35Cr 233.8Cr 91Cr 1.15TCr 94Cr 92Cr 4TCr EV / Sales 2024
3.04x
EV / Sales 2025 3.08x
Free-Float
17.54%
Yield 2024
1.5%
Yield 2025 -
11/05 Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2026 CI
07/05 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
07/03 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
06/11 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
08/25/08 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
09/25/09 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
08/25/08 Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2025 CI
08/25/08 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
06/24/06 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
13/24/13 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
07/24/07 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
11/24/11 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
10/23/10 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
1 day-1.88%
1 week-1.57%
Current month-4.57%
1 month-1.88%
3 months-9.01%
6 months-24.76%
Current year-20.76%
1 week 1,530
Extreme 1530
1,640
1 month 1,520
Extreme 1520
1,725
Current year 1,420
Extreme 1420
2,130
1 year 945
Extreme 945
2,300
3 years 480.5
Extreme 480.5
2,300
5 years 208.5
Extreme 208.5
2,300
10 years 24.8
Extreme 24.8
2,300
Manager TitleAgeSince
President - -
General Counsel - 29/04/2025
Corporate Officer/Principal - 29/04/2025
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-1.88%-1.57%+7.93%+205.07% 8.82Cr
-0.61%-1.94%+39.00%+150.72% 1,00100Cr
-0.20%-0.77%+51.51%+43.20% 57TCr
+0.40%-1.31%+16.56%+60.47% 39TCr
+0.48%+2.29%+24.04%+16.53% 33TCr
+0.66%+1.16%+26.00%+32.55% 28TCr
+0.65%-0.63%+25.48%+14.88% 28TCr
+3.63%+2.97%-40.27%-46.16% 19TCr
-0.77%+0.95%+17.69%+51.46% 19TCr
+2.36%+1.38%+14.80%+61.34% 16TCr
Average +0.56%+0.16%+18.27%+59.01% 33.77TCr
Weighted average by Cap. +0.47%-0.41%+28.03%+67.53%

Financials

2024 2025
Net sales 9.18TCr 6.4Cr 5.52Cr 5.08Cr 4.77Cr 8.96Cr 605.42Cr 9.05Cr 60Cr 23Cr 296.48Cr 24Cr 24Cr 1.03TCr 13TCr 8.84Cr 7.62Cr 7.02Cr 6.59Cr 12Cr 835.81Cr 12Cr 83Cr 32Cr 409.3Cr 33Cr 32Cr 1.42TCr
Net income 2.38TCr 1.66Cr 1.43Cr 1.32Cr 1.24Cr 2.33Cr 157.27Cr 2.35Cr 16Cr 6.08Cr 77Cr 6.24Cr 6.11Cr 266.9Cr 308.78Cr 21.54L 18.56L 17.09L 16.05L 30.13L 20Cr 30.45L 2.02Cr 78.69L 9.97Cr 80.84L 79.12L 35Cr
Net Debt 13TCr 9.32Cr 8.03Cr 7.4Cr 6.95Cr 13Cr 881.46Cr 13Cr 87Cr 34Cr 431.65Cr 35Cr 34Cr 1.5TCr 23TCr 16Cr 14Cr 13Cr 12Cr 23Cr 1.52TCr 23Cr 151.13Cr 59Cr 746.2Cr 60Cr 59Cr 2.59TCr
Logo Laboratorios Richmond S.A.C.I.F.
Laboratorios Richmond SACIF is an Argentina-based company, which is engaged in the development and manufacture of pharmaceuticals. The Company's product categories include: Antiviral, under the brands Ciganclor, Lazinevir, Leuzan, Mivuten, Probirase, Protease, Selmivir, Trivenz, Virontar, Virontar N, Virontar 600, Vuclodir, Zepril, Zetavudin, and Zetrotax; Oncologi and Oncohematologic, under the brands Bemux, Capecit, Doxetal, Drifen, Espasevit, Fontrax, Gezt, and Monofer, among others; Cardiovascular, under the brands Amze 5, Amze 10, Antiplaq, Bilip 10, Bilip 20, Tacardia, and Timezol 20, among others; Neuropsychiatric, under the brands Dalam 15, Dolofrix 10, Donepes 5, and Prilben 10, among others, as well as Hospital, under the brands Amidiaz, Dalam, and Fentax, among others.
Employees
620
Date Price Change Volume
16/26/16 1,565.00 $ -1.88% 4,012
12/26/12 1,595.00 $ -1.85% 2,362
11/26/11 1,625.00 $ +1.88% 2,208
10/26/10 1,595.00 $ +0.31% 5,402
09/26/09 1,590.00 $ -0.31% 35,894
  1. Stock Market
  2. Stocks
  3. RICH Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!